1. Home
  2. ABP vs USEA Comparison

ABP vs USEA Comparison

Compare ABP & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • USEA
  • Stock Information
  • Founded
  • ABP 2004
  • USEA 2004
  • Country
  • ABP United States
  • USEA Greece
  • Employees
  • ABP N/A
  • USEA N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • USEA Marine Transportation
  • Sector
  • ABP Health Care
  • USEA Consumer Discretionary
  • Exchange
  • ABP Nasdaq
  • USEA Nasdaq
  • Market Cap
  • ABP 12.1M
  • USEA 10.5M
  • IPO Year
  • ABP N/A
  • USEA N/A
  • Fundamental
  • Price
  • ABP $0.27
  • USEA $1.29
  • Analyst Decision
  • ABP Strong Buy
  • USEA Strong Buy
  • Analyst Count
  • ABP 1
  • USEA 1
  • Target Price
  • ABP $4.00
  • USEA $6.00
  • AVG Volume (30 Days)
  • ABP 17.5M
  • USEA 18.3K
  • Earning Date
  • ABP 05-22-2025
  • USEA 05-27-2025
  • Dividend Yield
  • ABP N/A
  • USEA 17.94%
  • EPS Growth
  • ABP N/A
  • USEA N/A
  • EPS
  • ABP N/A
  • USEA N/A
  • Revenue
  • ABP $183,000.00
  • USEA $45,439,000.00
  • Revenue This Year
  • ABP N/A
  • USEA N/A
  • Revenue Next Year
  • ABP N/A
  • USEA $11.02
  • P/E Ratio
  • ABP N/A
  • USEA N/A
  • Revenue Growth
  • ABP 50.00
  • USEA 25.98
  • 52 Week Low
  • ABP $0.23
  • USEA $1.00
  • 52 Week High
  • ABP $13.00
  • USEA $2.90
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • USEA 58.77
  • Support Level
  • ABP N/A
  • USEA $1.30
  • Resistance Level
  • ABP N/A
  • USEA $1.40
  • Average True Range (ATR)
  • ABP 0.00
  • USEA 0.04
  • MACD
  • ABP 0.00
  • USEA 0.03
  • Stochastic Oscillator
  • ABP 0.00
  • USEA 69.87

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About USEA United Maritime Corporation

United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.

Share on Social Networks: